公开(公告)号：KR1020090059017A

公开(公告)日：2009-06-10

申请号：KR1020080020870

申请日：2008-03-06

Applicant: 신풍제약주식회사

Inventor： 노정열 ,  강수현 ,  하경욱

IPC: A61K31/216 ,  A61K31/222 ,  A61K31/255

Abstract: A pharmaceutical composition for treating liver disease and improving liver function is provided to enhance the treatment effect of liver disease by mixing two kinds of antioxidant. A pharmaceutical composition for treating liver disease and improving liver function comprises biphenyl methyl dicarboxylate and arginine thiozolidine carboxylate in a weight ratio of 1-25:1-200 as active ingredients. The pharmaceutical composition contains 25mg of biphenyl methyl dicarboxylate and 200mg of arginine thiozolidine carboxylate. The pharmaceutical composition further comprises at least one of pharmaceutically allowable carrier. The composition is used in a form of tablet, capsule or suspension.

Abstract translation: 提供一种治疗肝脏疾病和改善肝功能的药物组合物，通过混合两种抗氧化剂来提高肝脏疾病的治疗效果。 用于治疗肝脏疾病和改善肝功能的药物组合物包括重量比为1-25：1-200的联苯甲基二羧酸酯和精氨酸硫唑烷羧酸盐作为活性成分。 药物组合物含有25mg联苯甲基二羧酸酯和200mg精氨酸硫唑烷羧酸盐。 药物组合物还包含药学上可允许的载体中的至少一种。 组合物以片剂，胶囊或悬浮液的形式使用。